Clinical Trials
3 trialsNCT06084780 2026-06-05
TRANSCAPE
Case Comprehensive Cancer Center
Phase 2 Not yet recruiting
NCT03821610 2026-05-05
ALL-RIC
University of Birmingham
Phase 2 Active not recruiting
NCT02711202 2026-04-13
Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Institute for Clinical and Experimental Medicine
Phase NA Completed